Hologic Launches ‘Better Is Possible’ Health Awareness Campaign for Women
11 Januar 2024 - 2:08PM
Business Wire
Leader in Women’s Health Encourages Women to
Stop Suffering in Silence and Talk to Their Doctor About Disruptive
Period Symptoms
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health,
today announced its new uterine health education and awareness
campaign Better is Possible™. Launching in New York, Los Angeles,
Atlanta and Detroit, the campaign seeks to increase awareness about
daily quality-of-life challenges such as heavy and disruptive
periods, pelvic pain and fibroids, while also educating women about
available treatment options.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240111778417/en/
Heavy and disruptive periods, also known as abnormal uterine
bleeding (AUB), affect more than 10 million U.S. women each year,
causing persistent symptoms like pain, tiredness, lack of energy
and long menstrual cycles with frequent changing of tampons and
pads.1 A common cause of AUB symptoms is uterine fibroids, which
77% of women will develop during their childbearing years.2 While
these uterine health issues are quite common, many women aren’t
aware of available treatment options.
“Roughly two-thirds of women say that their period has impacted
their day-to-day life, but until now, there’s been a glaring
absence of discussion around solutions.3 Through this campaign, we
want to show women who experience painful periods, uncontrolled
bleeding or other uterine health issues, that they don’t have to
suffer in silence,” said Mary Byerly, Vice President of Marketing
for Hologic’s Gynecological Surgical Solutions division. “When it
comes to periods, it can be so difficult to differentiate between
what is normal and what isn’t. We’re proud to equip women with the
resources they need to start the conversation and feel empowered
when talking to their doctor about their periods and play an active
role in their treatment plan.”
The Better Is Possible campaign includes a video highlighting
the experiences of women living with uterine health issues and
encourages those dealing with similar symptoms to talk to their
doctor. The campaign hub, BetterIsPossible.com, offers downloadable
materials such as a period symptom quiz, discussion guides and
information about potential treatment options.
“I’ve heard from patients who search online for information
about their symptoms and feel discouraged to discuss them with me
when they see hysterectomy listed as the only treatment option,”
said Danny Younes, MD, an obstetrician-gynecologist in San Diego.
“Minimally invasive options are game-changing for my patients who
seek relief from their painful fibroid symptoms but don’t want to
remove their uterus.”
In addition to educating patients, Hologic is also empowering
physicians to create tailored care plans for their patients by
providing cutting-edge, uterine-care technology with both surgical
and surgery-free solutions. For more information about how Hologic
is supporting physicians to discuss hysterectomy-alternative
treatment options, visit
gynsurgicalsolutions.com/hcp/for-medical-professionals/
For more information about the Better is Possible campaign and
to access educational resources, visit BetterIsPossible.com.
About Hologic, Inc.
Hologic, Inc. is a global medical technology innovator focused
on improving the health and well-being of women, their families and
communities through early detection and treatment. Its advancements
include invention of the world’s first commercial 3D mammography
system to find breast cancer earlier; leadership in testing for
cervical cancer, sexually transmitted infections and respiratory
illnesses; and minimally invasive surgical technologies for uterine
fibroids and abnormal uterine bleeding.
Hologic, The Science of Sure, Better is Possible and associated
logos are trademarks and/or registered trademarks of Hologic, Inc.
and/or its subsidiaries in the United States and/or other
countries.
SOURCE: Hologic, Inc.
References
1 Centers for Disease Control and Prevention. Heavy menstrual
bleeding.
https://www.cdc.gov/ncbddd/blooddisorders/women/menorrhagia.html.
Accessed January 3, 2024. 2 Johns Hopkins. Fibroids.
https://www.hopkinsmedicine.org/health/conditions-and-diseases/uterine-fibroids.
Accessed January 3, 2024. 3 This survey was conducted online within
the United States by The Harris Poll on behalf of Hologic between
May 10-12, 2022, among 997 female adults ages 18+.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240111778417/en/
Media Contact: Bridget Perry Director, Corporate
Communications +1 508.263.8654 bridget.perry@hologic.com
Investor Contact: Ryan Simon Vice President, Investor
Relations +1 858.410.8514 ryan.simon@hologic.com
Hologic (NASDAQ:HOLX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Hologic (NASDAQ:HOLX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024